Gemcitabine plus vinorelbine as an effective salvage chemotherapeutic regimen in advanced Hodgkin lymphoma

Hematology/ Oncology and Stem Cell Therapy

Volumn 2, Issue 2, 2009, Pages 371-372

  Chen, Jia Hong ^b   Chang, Ping Ying ^b   Yao, Nai Shun ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; NAVELBINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; VINBLASTINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE;

ABSENCE OF SIDE EFFECTS; ADULT; ADVANCED CANCER; ALOPECIA; ANEMIA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEBRILE NEUTROPENIA; FEMALE; HEART ARRHYTHMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOSPLENOMEGALY; HODGKIN DISEASE; HUMAN; HYPERTENSION; LETTER; LEUKOPENIA; LYMPHADENOPATHY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; RELAPSE; REMISSION; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR LOCALIZATION; ANALOGS AND DERIVATIVES; PATHOLOGY; SALVAGE THERAPY; SURVIVAL RATE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; FEMALE; HODGKIN DISEASE; HUMANS; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; VINBLASTINE;

EID: 77953667896     PISSN: 16583876     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1658-3876(09)50030-1     Document Type: Letter

References (11)

1. Yasuhiro O, Anas Y. Current role of gemcitabine in the treatment of Hodgkin lymphoma. Leuk Lymph. 2008;49: 883-889. (Pubitemid 351942740)
2. Pasricha SR, Grigg A, Catalano J, Leahy M, Underhill C, Arthur C, D'Rozario J, Lowenthal R, Reed K, Spencer A. A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma. Cancer. 2008 Dec 1;113(11):3192-3198
3. Validire P, Ferme C, Brice P, Divine M, Gabarre J, Bouabdallah K, Fitoussi O, Chaoui D, Pacquement H, Soussain C, Carde P, Salhi R, Zanni M, Decaudin D. A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients. Anticancer Drugs. 2008 Mar;19(3):309-315
4. Devizzi L, Santoro A, Bonfante V, Viviani S, Balzarini L, Valagussa P, Bonadonna G. Vinorelbine: An active drug for the management of patients with heavily pretreated Hodgkin's disease. Annals of Oncology 1994;5: 817-820. (Pubitemid 24341874)
5. Chen YM, Perng RP, Yang KY, Liu TW, Tsai CM, Ming-Liu J, Whang-Peng J. A multicenter phase II trial of vinorelbine plus Gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer. Chest. 2000;117:1583-1589. (Pubitemid 30413348)
6. Martin M, Ruiz A, Munoz M, Balil A, Garcia-Mata J, Calvo L, Carrasco E, Mahillo E, Casado A, Garcia-Saenz JA, Escudero MJ, Guillem V, Jara C, Ribelles N, Salas F, Soto C, Morales-Vasquez F, Rodriguez CA, Adrover E, Mel JR. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial. Lancet Oncol. 2007;8:219-225. (Pubitemid 46291704)
7. Papageorgiou ES, Tsirigotis P, Dimopoulos M, Pavidis N, Fountzilas G, papageorgiou S, Economopoulos T. Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group. Eur J Haematol. 2005;75:124-129 (Pubitemid 41008282)
8. Perrotti AP, Niscola P, Tendas A, Scaramucci L, Palombi M, Cupeli L, Dentamaro T, Piccioni D, Giovannini M, de Fabritis P. Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin's lymphoma patients. Ann Hematol. 2008;87:493-494.
9. Eghbali H. Phase II study of vinorelbine (navelbine) in previously treated Hodgkin's disease and non Hodgkin's lymphoma.In Solal-Celigny P (ed): Navelbine Update and NewTrends. John Libbey Eurotext LTD, Paris, France 1991;253-260.
10. Benchekroun S, Chouffai Z, Harif M. Clinical study del' efficacite' of Navelbine in the disease of Hodgkin. Test of phase H In; Navelbine actualites and prospects. Paris: Pierre Fabre Oncology Ed. 1990; 267-270.
11. a.